Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
03/2014
03/18/2014US8673896 Benzodiazepine and pyridodiazepine derivatives
03/18/2014US8673890 2,3-dihydro-1H-isoindol-1-imine derivatives useful as thrombin PAR-1 receptor antagonist
03/18/2014US8673818 C2-phenyl-substituted cyclic ketonols
03/18/2014CA2719538C Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
03/18/2014CA2683098C Process for making galantamine
03/13/2014WO2014039769A1 Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
03/13/2014WO2014039714A2 Compounds and methods for kinase modulation, and indications therefor
03/13/2014WO2014039489A1 Spirocyclic derivatives as antiparasitic agents
03/13/2014WO2014039484A1 Spirocyclic isoxazolines as antiparasitic agents
03/13/2014WO2014039412A1 Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
03/13/2014WO2014038867A1 A novel combination of a host compound and a dopant compound and an organic electroluminescence device comprising the same
03/13/2014WO2014037751A1 Pharmacologically active compounds
03/13/2014WO2012074857A3 Improved process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines
03/13/2014US20140073642 Quinazoline derivatives for the treatment of viral infections and further diseases
03/13/2014US20140073635 Substituted Imidazopyridinyl-Aminopyridine Compounds
03/12/2014EP2705041A1 Crystalline salts of asenapine
03/12/2014EP2705030A1 Partially saturated tricyclic compounds and methods of making and using same
03/12/2014CN103635474A Tricyclic antibiotics
03/12/2014CN103626784A Phosphorescent emitters with phenylimidazole ligands
03/12/2014CN103626783A Dicyclic fused heterocyclic compounds, and applications and pharmaceutical compositions thereof
03/12/2014CN102351870B Method for preparing benzacridine derivative and application of benzacridine derivative as anti-cancer medicine
03/12/2014CN101998958B Thieno-and furo-pyrimidine modulators of histamine H4 receptor
03/12/2014CN101801980B Tricyclic heterocyclic derivatives
03/12/2014CN101675053B Phosphoinositide 3-kinase inhibitor compounds and methods of use
03/11/2014US8669372 Process for preparing dithiine-tetracarboxy-diimides
03/11/2014US8669269 Imidazopyridine derivatives which inhibit the secretion of gastric acid
03/11/2014CA2709571C Process for preparing tetrahydroquinoline derivatives
03/06/2014WO2014036056A1 Crystalline forms of 1-(5'-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-3'h-spiro[azetidine-3,1'-isobenzofuran]-1-yl)-2-(methylsulfonyl)ethanone
03/06/2014WO2014035224A1 New photochromic compounds, method of production thereof and intermediate compounds
03/06/2014WO2014034584A1 Organic electroluminescent element, illuminator, and display device
03/06/2014WO2014033196A1 Dioxino- and oxazin-[2,3-d]pyrimidine pi3k inhibitor compounds and methods of use
03/06/2014WO2014007951A3 Substituted tricyclic compounds as fgfr inhibitors
03/06/2014US20140066479 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
03/06/2014US20140066470 Novel formulations of water-insoluble chemical compounds and methods of using a formulation of compound fl118 for cancer therapy
03/06/2014US20140066433 Fused heterocyclic derivatives as s1p modulators
03/06/2014US20140066430 Aurora kinase modulators and method of use
03/06/2014US20140065136 Dioxino- and oxazin-[2,3-d]pyrimidine pi3k inhibitor compounds and methods of use
03/05/2014EP2703405A2 New materials with aza-dibenzothiophene or aza-dibenzofuran core for pholed
03/05/2014EP2703401A1 Pyridine derivative and bace-1 inhibitor containing same
03/05/2014EP2703394A1 Novel 3-hydroxyisothiazole 1-oxide derivative
03/05/2014CN103620808A Organic electroluminescent element
03/05/2014CN103613599A Bay-site cyclization synthetic method of 3, 4:9, 10-perylenetetracarboxylic bisimide
03/04/2014US8664396 Photoluminescent metal complexes for protein staining
03/04/2014US8664387 Pyridoquinazolinone M1 receptor positive allosteric modulators
03/04/2014US8664217 Benzodiazepine compound and pharmaceutical composition
03/04/2014US8664213 Spiro bicyclic diamine derivatives as HIV attachment inhibitors
02/2014
02/27/2014WO2014031762A1 Benzocyclooctyne compounds and uses thereof
02/27/2014WO2014029684A1 Pesticidally active pyridyl- and pyrimidyl- substituted pyrazole derivatives
02/27/2014WO2014029014A1 Thieno, furo and selenopheno-[3,4-c]pyrrole-4,6-dione copolymers
02/27/2014US20140058067 Immunoconjugates with an Intracellularly-Cleavable Linkage
02/27/2014US20140057932 1,3-Dioxanomorphides and 1,3-Dioxanocodides
02/26/2014EP2700642A1 Camptothecin compound containing stable 7-membered lactone ring, preparation method and use
02/26/2014EP2699571A2 Materials for organic electroluminescent devices
02/26/2014EP2699558A1 Benzothiazole compounds and their pharmaceutical use
02/26/2014CN103608332A Pyridin-2-amides useful as CB2 agonists
02/26/2014CN103601731A Semi-synthesis method of aristololactam
02/26/2014CN103601730A Crown ether ring-shaped quinazoline nitrogen mustard compound, and preparation method and application thereof in tumor treatment
02/26/2014CN103087072B (+)-Tricyclic hydroxy lactone preparation method
02/26/2014CN102471317B Aminopyridine derivatives for treating tumors and inflammatory diseases
02/26/2014CN102382129B Spirocycles-substituted phosphodiesterase inhibitor
02/25/2014US8658670 Methods and compounds for treatment of clostridium based infection
02/25/2014US8658665 3,6-disubstituted xanthylium salts and use thereof in treatment of tauopathies
02/25/2014US8658649 Kinase inhibitor
02/25/2014CA2404868C C2-phenyl-substituted cyclic keto-enols as pesticides and herbicides
02/20/2014WO2014028801A1 Cyclopentylpyrazoles as n-type calcium channel blockers
02/20/2014WO2014028272A1 Wellbore servicing compositions and methods of making and using same
02/20/2014WO2014026254A1 Pharmaceutical formulations containing 3-(4-cinnamyl-l-piperazinyl) amino derivatives of 3-formylrifamycin sv and 3-formylrifamycin s and a process of their preparation
02/20/2014WO2013149996A9 Substituted tricyclic compounds with activity towards ep1 receptors
02/20/2014US20140051741 Crystalline salts of asenapine
02/20/2014US20140051692 Inhibitors of Human Immunodeficiency Virus Replication
02/20/2014US20140051678 Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases
02/20/2014US20140051677 Novel compound useful for the treatment of degenerative and inflammatory diseases
02/20/2014US20140051676 Triazine-oxadiazoles
02/20/2014US20140051660 Cyclopentylpyrazoles as n-type calcium channel blockers
02/19/2014EP2697199A1 Aryl-or heteroaryl-substituted benzene compounds
02/19/2014EP2697198A1 Substituted benzene compounds
02/19/2014CN103588776A Compound with anti-tumor function in zephyranthes candida as well as separation preparation method and application of compound
02/19/2014CN103588718A Novel triazinedione derivatives as GABAB receptor modulators
02/19/2014CN103588704A Inhibitors of focal adhesion kinase
02/18/2014US8653280 Process for the preparation of asenapine
02/18/2014US8653268 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
02/18/2014US8653127 Bicyclic pyrazolo-heterocycles
02/18/2014US8653098 Pyrazolopyridine PI3K inhibitor compounds and methods of use
02/18/2014US8653096 Chemokine receptor antagonists and methods of use thereof
02/18/2014US8653079 Pyrazolo [4,3-C] cinnolin-3-one M1 receptor positive allosteric modulators
02/18/2014US8653065 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
02/18/2014US8652479 Antibody-drug conjugates and methods
02/18/2014CA2716706C Compounds and compositions as tlr activity modulators
02/13/2014WO2014025736A1 Hcv ns3 protease inhibitors
02/13/2014WO2014025651A1 Chroman derivatives as trpm8 inhibitors
02/13/2014US20140046055 Compounds and methods for inhibiting mitotic progression
02/13/2014US20140045875 Fused and Spirocycle Compounds and the Use Thereof
02/13/2014US20140045869 Dna-pk inhibitors
02/13/2014US20140045865 2-amino-4-arylthiazole compounds as trpa1 antagonists
02/13/2014US20140045855 Chroman derivatives as trpm8 inhibitors
02/13/2014US20140045833 Protein Kinase Inhibitors
02/13/2014US20140045818 Benzothiazole compounds and their pharmaceutical use
02/13/2014US20140045793 Quinolone compound and pharmaceutical composition
02/13/2014US20140045790 Novel Bicyclic Pyridinones
02/13/2014US20140045779 Compounds containing an alicyclie structure and anti-tumor application
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 298